Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors
Clinical trial NCT00878423 · COMPLETED
Trial details
- NCT number
- NCT00878423
- Sponsor
- Astex Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2013-05-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.